TY  - CONF

T1  - There is a general loss of expression of receptor activator of nFkB ligand (RANKL) in human breast cancers but retention of expression has a significant negative association with expression of oestrogen receptor (ER)

JO  - JOURNAL OF PATHOLOGY

PY  - 2005/10/01

AU  - Cross SS

AU  - Balasubramanian SP

AU  - Lippitt JM

AU  - Evans CA

AU  - Reed MWR

AU  - Holen I

ED  - 

VL  - 207

SP  - 27

EP  - 27

Y2  - 2024/12/29

ER  -